Analyst Ratings for Cue Biopharma (CUE)
CUE Rating Summary
CUE Price Target Summary
- Highest: $4.00 (Lucid Capital Markets)
- Lowest: $2.00 (Citizens)
- Average: $3.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$3.00 (+900%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$3.00 (+900%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/25/2025 | Lucid Capital Markets | Dev Prasad | New Coverage | Buy (N/A) |
4.00 (N/A) |
0.83 (0.30) |
-63.86% | Details |
| 3/13/2024 | Jefferies » Updated 11/15/2024 |
Maury Raycroft | New Coverage | Buy (N/A) |
4.00 (6.00) |
1.90 (0.30) |
-84.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
